{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:09:11Z","timestamp":1792786151336,"version":"4.5.0"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"37","license":[{"start":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T00:00:00Z","timestamp":1757635200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"he Beijing Municipal Science & Technology Commission","award":["Z221100007422005"],"award-info":[{"award-number":["Z221100007422005"]}],"id":[{"id":"https:\/\/ror.org\/034k14f91","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,9,12]]},"abstract":"<jats:p>Nonalcoholic fatty liver disease (NAFLD) is a growing global health concern due to its increasing prevalence and potential to cause serious liver complications. NAFLD is rising among people aged 15 to 49 years, a critical age group for workforce and reproduction, yet its burden and trends in this population remain insufficiently studied. This study aimed to evaluate the prevalence, incidence, mortality, and disability-adjusted life years (DALYs) associated with NAFLD in this age group across 204 countries and territories from 1990 to 2021, using data from the global burden of disease (GBD) 2021 database. Trends in disease burden were assessed using average annual percentage change (AAPC), with stratified analyses by sex, age, and socio-demographic index (SDI). Bayesian age-period-cohort (BAPC) models were employed to project future trends and quantify the contributions of major risk factors. By 2021, the global incidence, prevalence, mortality, and DALY rates of NAFLD in people aged 15 to 49 years were 909.48 per 100,000 persons (95% UI: 647.19\u20131216.77), 16,580.43 per 100,000 persons (95% UI: 12,851.14\u201320,866.60), 0.45 per 100,000 persons (95% UI: 0.27\u20130.72), and 22.77 per 100,000 person-years (95% UI: 13.74\u201335.81), respectively. Between 1990 and 2021, both incidence and prevalence increased, whereas mortality and DALYs remained relatively stable. NAFLD burden declined as SDI increased, peaking at an SDI of approximately 0.6 before gradually decreasing. Males consistently exhibited higher burden than females. The leading contributors to age-standardized mortality were tobacco use and elevated fasting glucose, with the impact of metabolic risk factors rising over time. Burden increased with age, with incidence peaking at age 22.5 and subsequently declining. By 2050, the number of new NAFLD cases among people aged 15 to 49 years is projected to reach 48.29 million globally, with the number of deaths expected to rise to 23,396.5. The substantial increase in NAFLD burden over the past 3 decades highlights the urgent need for early screening and diagnosis. These findings may inform future public health planning aimed at reducing the disease burden among people aged 15 to 49 years.<\/jats:p>","DOI":"10.1097\/md.0000000000044527","type":"journal-article","created":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T21:00:37Z","timestamp":1757970037000},"page":"e44527","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Global, regional, and national burden of nonalcoholic fatty liver disease (NAFLD) among people aged 15 to 49 years from 1990 to 2021, with projections to 2050: A systematic analysis based on the 2021 global burden of disease study"],"prefix":"10.1097","volume":"104","author":[{"given":"Mengqin","family":"Wang","sequence":"first","affiliation":[{"name":"Bariatric and Metabolic Surgery, Capital Medical University Affiliated Beijing Shijitan Hospital, Beijing, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiqige","family":"Wuyun","sequence":"additional","affiliation":[{"name":"Bariatric and Metabolic Surgery, Capital Medical University Affiliated Beijing Shijitan Hospital, Beijing, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongbo","family":"Lian","sequence":"additional","affiliation":[{"name":"Bariatric and Metabolic Surgery, Capital Medical University Affiliated Beijing Shijitan Hospital, Beijing, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangzhong","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of general surgery, Capital Medical University Affiliated Beijing Tiantan Hospital, Beijing, People\u2019s Republic of China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangyi","family":"Zhu","sequence":"additional","affiliation":[{"name":"Bariatric and Metabolic Surgery, Capital Medical University Affiliated Beijing Shijitan Hospital, Beijing, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9412-2652","authenticated-orcid":false,"given":"Nengwei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Bariatric and Metabolic Surgery, Capital Medical University Affiliated Beijing Shijitan Hospital, Beijing, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260923","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S2468-1253(19)30342-5","article-title":"Liver diseases in the Asia-Pacific region: a Lancet Gastroenterology & Hepatology Commission.","volume":"5","author":"Sarin","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R2-20260923","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1002\/hep.30251","article-title":"Global perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.","volume":"69","author":"Younossi","year":"2019","journal-title":"Hepatology"},{"key":"R3-20260923","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.jhep.2021.05.003","article-title":"The Chinese Society of Hepatology position statement on the redefinition of fatty liver disease.","volume":"75","author":"Nan","year":"2021","journal-title":"J Hepatol"},{"key":"R4-20260923","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes.","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"R5-20260923","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases.","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"key":"R6-20260923","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jhep.2018.10.033","article-title":"Non-alcoholic fatty liver disease - a global public health perspective.","volume":"70","author":"Younossi","year":"2019","journal-title":"J Hepatol"},{"key":"R7-20260923","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1053\/j.gastro.2019.12.053","article-title":"AGA clinical practice update on screening and surveillance for hepatocellular carcinoma in patients with nonalcoholic fatty liver disease: expert review.","volume":"158","author":"Loomba","year":"2020","journal-title":"Gastroenterology"},{"key":"R8-20260923","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/s41575-021-00523-4","article-title":"Advancing the global public health agenda for NAFLD: a consensus statement.","volume":"19","author":"Lazarus","year":"2022","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R9-20260923","doi-asserted-by":"crossref","first-page":"22232","DOI":"10.1038\/s41598-024-72795-0","article-title":"Global burden of metabolic dysfunction-associated steatotic liver disease attributable to high fasting plasma glucose in 204 countries and territories from 1990 to 2021.","volume":"14","author":"Yang","year":"2024","journal-title":"Sci Rep"},{"key":"R10-20260923","doi-asserted-by":"crossref","first-page":"1047129","DOI":"10.3389\/fnut.2022.1047129","article-title":"Changes in the global, regional, and national burdens of NAFLD from 1990 to 2019: a systematic analysis of the global burden of disease study 2019.","volume":"9","author":"Wang","year":"2022","journal-title":"Front Nutr"},{"key":"R11-20260923","doi-asserted-by":"crossref","first-page":"1230457","DOI":"10.3389\/fendo.2023.1230457","article-title":"Serum metabolomic profiling unveils distinct sex-related metabolic patterns in NAFLD.","volume":"14","author":"Fotakis","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R12-20260923","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1016\/S0140-6736(24)00769-4","article-title":"Findings from the Global Burden of Disease Study 2021.","volume":"403","author":"Murray","year":"2024","journal-title":"Lancet"},{"key":"R13-20260923","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0140-6736(23)01301-6","article-title":"Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021.","volume":"402","year":"2023","journal-title":"Lancet"},{"key":"R14-20260923","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","article-title":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.","volume":"396","year":"2020","journal-title":"Lancet"},{"key":"R15-20260923","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.jhep.2018.12.001","article-title":"The trends in incidence of primary liver cancer caused by specific etiologies: results from the Global Burden of Disease Study 2016 and implications for liver cancer prevention.","volume":"70","author":"Liu","year":"2019","journal-title":"J Hepatol"},{"key":"R16-20260923","doi-asserted-by":"crossref","first-page":"103359","DOI":"10.1016\/j.autrev.2023.103359","article-title":"Temporal trends in the prevalence of autoimmune diseases from 1990 to 2019.","volume":"22","author":"Cao","year":"2023","journal-title":"Autoimmun Rev"},{"key":"R17-20260923","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1001\/jamaoncol.2016.5688","article-title":"Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the Global Burden of Disease Study.","volume":"3","author":"Fitzmaurice","year":"2017","journal-title":"JAMA Oncol"},{"key":"R18-20260923","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1007\/s13524-013-0243-z","article-title":"Assessing validity and application scope of the intrinsic estimator approach to the age-period-cohort problem.","volume":"50","author":"Luo","year":"2013","journal-title":"Demography"},{"key":"R19-20260923","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.puhe.2022.04.015","article-title":"Global disease burden of COPD from 1990 to 2019 and prediction of future disease burden trend in China.","volume":"208","author":"Hu","year":"2022","journal-title":"Public Health"},{"key":"R20-20260923","doi-asserted-by":"crossref","first-page":"102068","DOI":"10.1016\/j.clinre.2022.102068","article-title":"Global burden of non-alcoholic fatty liver disease in 204 countries and territories from 1990 to 2019.","volume":"47","author":"Tian","year":"2023","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"R21-20260923","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1002\/hep.30161","article-title":"Changing trends in etiology-based and ethnicity-based annual mortality rates of cirrhosis and hepatocellular carcinoma in the United States.","volume":"69","author":"Kim","year":"2019","journal-title":"Hepatology"},{"key":"R22-20260923","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.jhep.2018.05.036","article-title":"Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030.","volume":"69","author":"Estes","year":"2018","journal-title":"J Hepatol"},{"key":"R23-20260923","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/S0140-6736(20)30977-6","article-title":"Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950\u20132019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019.","volume":"396","year":"2020","journal-title":"Lancet"},{"key":"R24-20260923","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jhep.2023.04.002","article-title":"Using the ELF test, FIB-4 and NAFLD fibrosis score to screen the population for liver disease.","volume":"79","author":"Kjaergaard","year":"2023","journal-title":"J Hepatol"},{"key":"R25-20260923","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.jhep.2024.04.031","article-title":"EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD).","volume":"81","year":"2024","journal-title":"J Hepatol"},{"issue":"1 Suppl 1","key":"R26-20260923","first-page":"S6","article-title":"Summary of revisions: standards of care in diabetes-2025.","volume":"48","year":"2025","journal-title":"Diabetes Care"},{"key":"R27-20260923","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies.","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat Med"},{"key":"R28-20260923","doi-asserted-by":"crossref","first-page":"109199","DOI":"10.1016\/j.cbi.2020.109199","article-title":"High fat diet-triggered non-alcoholic fatty liver disease: a review of proposed mechanisms.","volume":"330","author":"Lian","year":"2020","journal-title":"Chem Biol Interact"},{"key":"R29-20260923","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s11892-021-01383-7","article-title":"The relationship between type 2 diabetes, NAFLD, and cardiovascular risk.","volume":"21","author":"Caussy","year":"2021","journal-title":"Curr Diab Rep"},{"issue":"Suppl","key":"R30-20260923","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.3350\/cmh.2022.0365","article-title":"Global incidence and prevalence of nonalcoholic fatty liver disease.","volume":"29","author":"Teng","year":"2023","journal-title":"Clin Mol Hepatol"},{"key":"R31-20260923","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1001\/jama.2015.5370","article-title":"Nonalcoholic fatty liver disease: a systematic review.","volume":"313","author":"Rinella","year":"2015","journal-title":"JAMA"},{"key":"R32-20260923","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/2042-6410-3-13","article-title":"Sex differences in human adipose tissues - the biology of pear shape.","volume":"3","author":"Karastergiou","year":"2012","journal-title":"Biol Sex Differ"},{"key":"R33-20260923","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.cgh.2015.07.024","article-title":"Body fat distribution and risk of incident and regressed nonalcoholic fatty liver disease.","volume":"14","author":"Kim","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R34-20260923","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1007\/s40618-022-01848-w","article-title":"Sex-specific metabolic risk factors and their trajectories towards the non-alcoholic fatty liver disease incidence.","volume":"45","author":"Tong","year":"2022","journal-title":"J Endocrinol Invest"},{"key":"R35-20260923","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S2213-8587(14)70032-4","article-title":"Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome.","volume":"2","author":"Yki-J\u00e4rvinen","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"R36-20260923","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","article-title":"Non-alcoholic fatty liver disease.","volume":"397","author":"Powell","year":"2021","journal-title":"Lancet"},{"key":"R37-20260923","doi-asserted-by":"crossref","first-page":"e162533","DOI":"10.1172\/JCI162533","article-title":"Mitochondria- and NOX4-dependent antioxidant defense mitigates progression to nonalcoholic steatohepatitis in obesity.","volume":"134","author":"Greatorex","year":"2023","journal-title":"J Clin Invest"},{"key":"R38-20260923","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/s41586-022-05299-4","article-title":"Gut bacteria alleviate smoking-related NASH by degrading gut nicotine.","volume":"610","author":"Chen","year":"2022","journal-title":"Nature"},{"key":"R39-20260923","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention.","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R40-20260923","doi-asserted-by":"crossref","first-page":"e0300","DOI":"10.1097\/HC9.0000000000000300","article-title":"Effect of combined tobacco use and type 2 diabetes mellitus on prevalent fibrosis in patients with MASLD.","volume":"7","author":"Balogun","year":"2023","journal-title":"Hepatol Commun"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000044527","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T18:01:45Z","timestamp":1790186505000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000044527"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,12]]},"references-count":40,"journal-issue":{"issue":"37","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000044527","relation":{},"ISSN":["1536-5964","0025-7974"],"issn-type":[{"value":"1536-5964","type":"electronic"},{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9,12]]},"assertion":[{"value":"2025-05-18","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-26","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}